Responses
Clinical and epidemiological research
Extended report
A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate
Compose a Response to This Article
Other responses
No responses have been published for this article.